Filing Details
- Accession Number:
- 0000899243-19-013254
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-13 17:01:17
- Reporting Period:
- 2019-05-09
- Accepted Time:
- 2019-05-13 17:01:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1563880 | Trevi Therapeutics Inc. | TRVI | Pharmaceutical Preparations (2834) | 450834299 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1659119 | Aperture Venture Partners Iv, L.p. | 645 Madison Avenue, 20Th Floor New York NY 10022 | No | No | Yes | No | |
1775271 | Aperture Ventures Iv Management, Llc | 645 Madison Avenue, 20Th Floor New York NY 10022 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-05-09 | 232,963 | $0.00 | 232,963 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2019-05-09 | 112,000 | $10.00 | 344,963 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series C Preferred Stock | Disposition | 2019-05-09 | 2,054,795 | $0.00 | 232,963 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct |
Footnotes
- On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- Aperture Ventures IV Management, LLC, the general partner of Aperture Venture Partners IV, L.P., has sole voting and investment control with respect to shares of the Issuer's common stock held by Aperture Venture Partners IV, L.P.